Document is current

Article History

Received: 22 November 2017

Accepted: 26 April 2018

First Online: 6 September 2018

Ethics approval and consent to participate

: This article does not contain any studies with human participants or animals performed by any of the authors.

: Not applicable.

: Mabel Crescioni and Mira Patel report no employment in a pharmaceutical company nor do they hold stocks, shares, or stock options in a pharmaceutical company. Katherine Gries reports she is a current employee at Janssen but reports no stocks, shares, nor options. Anna Rydén is an employee and shareholder of AstraZeneca. Jennifer T. Hanlon is a salaried employee who owns stocks, shares, and stock options at Ironwood Pharmaceuticals. April N. Naegeli is a salaried employee who owns stocks, shares, and stock options at Eli Lilly and Company. Shima Safikhani and Margaret Vernon are employees of Evidera, a research and consulting firm to the biopharma industry and, as such, are not allowed to accept remuneration from any Evidera clients. None of these authors report any other arrangements that could be perceived as conflicts of interest.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.